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CASE REPORT
Transient normoprolactinemic galactorrhea induced by fluoxetine
Fluoksetine bağlı, geçici normoprolaktinemik galaktore
Fatih Canan1, Ünsal Aydınoğlu2, Gjergji Sinani3
ÖZET
Antidepresanlara bağlı hormonal yan etkiler sık görülme-
mektedir.  Galaktore,  antidepresanlara  bağlı  yan  etkiler 
arasında nadiren bildirilmiştir. Antidepresanlar, hipotala-
mustaki postsinaptik 5-Hidroksitriptamin (5-HT) reseptör-
lerini doğrudan uyararak veya tuberoinfindibuler dopami-
nerjik nöronları 5-HT üzerinden dolaylı olarak inhibe ede-
rek prolaktin seviyelerinde artışa ve sonuçta galaktoreye 
neden olabilirler. Ancak antidepresan tedavisi sırasında 
normal prolaktin seviyelerine rağmen galaktore gelişebilir. 
Bu çalışmada fluoksetin tedavisi ile ilişkili normoprolakti-
nemik galaktore gelişen bir kadın olgu sunulacaktır. Bu 
olgu sunumu ile selektif serotonin gerialım inhibitörlerine 
bağlı galaktorenin tanımlanmamış mekanizmalarının var-
lığı üzerine vurgu yapılacaktır.
Anahtar kelimeler: Fluoksetin, galaktore, yan etki
ABSTRACT
Hormonal side effects of antidepressants are infrequent. 
Galactorrhea  is  rarely  reported  among  antidepressant 
related side effects. Antidepressants can directly stimu-
late postsynaptic 5- Hydroxytryptamine (5-HT) receptors 
in the hypothalamus or indirectly inhibit the tuberoinfun-
dibular dopaminergic neurons through 5-HT, which may 
increase  prolactin  levels  and  later  cause  galactorrhea. 
However, galactorrhea may develop despite normal pro-
lactin levels during antidepressant treatment. We present 
a case of normoprolactinemic galactorrhea in a woman, 
related  with  fluoxetine  treatment. This  report  highlights 
the  presence  of  unidentified  mechanisms  of  selective 
serotonin reuptake inhibitor induced galactorrhea. J Clin 
Exp Invest 2013; 4 (1): 105-106
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INTRODUCTION
Several drugs can cause galactorrhea, and it needs 
to be differentiated from other local or neuroendo-
crinological causes. All conventional antipsychotic 
drugs block D2 receptors on lactotroph cells and 
thus remove the main inhibitory influence on pro-
lactin secretion.1 Tricyclic antidepressants and se-
lective serotonin reuptake inhibitors (SSRI) are less 
frequent causes.2,3 There is evidence that serotonin 
may stimulate prolactin release directly via postsyn-
aptic 5- Hydroxytryptamine (5-HT) receptors in the 
hypothalamus,4 or indirectly via 5-HT mediated inhi-
bition of tubuloinfundibular dopaminergic neurons.5 
However,  galactorrhea  due  to  antidepressants  is 
not consistently associated with elevated prolactin 
levels, which may suggest still unexplained mecha-
nisms of antidepressant-induced galactorrhea.6,7
Herein,  we  report  a  case  of  euprolactinemic 
galactorrhea in a woman with generalized anxiety 
disorder while on treatment with fluoxetine.
CASE
A  29-year-old  woman  with  two  children  visited  a 
psychiatric outpatient clinic with complaints of ex-
cessive and uncontrollable worry about minor life 
events,  feeling  restlessness,  irritability,  muscle 
tension, tiring easily, and poor sleep that started 8 
months prior to admission. She had no history of 
endocrine or reproductive pathology or psychiatric 
problems. She was diagnosed as generalized anxi-
ety disorder according to DSM-IV criteria and was 
started on fluoxetine 20 mg per day. After 4 weeks 
of medication, her complaints declined. However, 
she developed unilateral galactorrhea (the nonpu-
erperal discharge of milk-containing fluid from the 
breast).  She  had  no  history  of  galactorrhea,  thy-
roid  disease,  and  polycystic  ovary  disease.  She 
first noticed the discharge on treatment day 21 and 
described it as white-creamy and from right nipple. 
She did not notice any bloody, greenish, or foul-
smelling  discharge  nor  report sexual  dysfunction. 
She consulted her gynecologist, who recommend-Canan et al. Galactorrhea induced by fluoxetine 106
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ed mammogram and breast ultrasonography. The 
pregnancy test was negative. The results of these 
tests and breast examination were normal. Serum 
prolactin level on treatment day 28 was 18.18 ng/
mL (reference range: 2.5-29 ng/mL). Because her 
galactorrhea developed after initiations of her medi-
cation with fluoxetine, her medication was discon-
tinued. Buspirone 5 mg/day treatment was started 
and gradually raised to 20 mg/d. Eight days after 
stopping fluoxetine, the patient reported reduction 
and cessation of galactorrhea. During 3 months of 
follow-up, the patient maintained well on buspirone 
and there was no reemergence of galactorrhea.
DISCUSSION
Galactorrhoea caused by the use of fluoxetine has 
been reported earlier and the commonly perceived 
cause is hyperprolactinemia.8 Fluoxetine has been 
shown to potentiate elevation of prolactin levels in-
ducing other stimuli, including insulin, fenfluramine, 
and 5-HT.9 However, hyperprolactinemia is not the 
only mechanism responsible for the development of 
SSRI-induced galactorrhoea.6,7 The exact mecha-
nism of galactorrhoea remains unknown in many 
cases. 
Our  patient  developed  galactorrhoea  without 
hyperprolactinemia after begining fluoxetine thera-
py. The strict temporal relationship between the use 
of the drug and the onset of galactorrhoea, as well 
as the resolution once treatment was discontinued, 
suggests a causal link between the two phenom-
ena. Although  unilateral  galactorrhea  induced  by 
psychotropic medications is rare,10 our patient de-
veloped unilateral galactorrhea with normal mam-
mogram  and  breast  ultrasonography,  indicating  a 
complex relationship between antidepressant use 
and galactorrhea.
To the best of our knowledge, we are the first to 
report an association with fluoxetine use and galac-
torrhea without elevated prolactin level. Clinicians 
should consider fluoxetine as a possible cause of 
galactorrhea even with normal prolactin levels. Fu-
ture research should investigate the exact mecha-
nisms  of  antidepressant-induced  normoprolactin-
emic galactorrhea.
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